Silk Road Medical Inc. Stock News

Silk Road Medical (NASDAQ: SILK ) stock is falling hard on Wednesday after the medical device company released preliminary earnings results for Q3 2023. A press release from Silk Road Medical reveals

Two pieces of news are weighing on shares of the medical devices company.

Shares of Thor Industries Inc. THO rose 2% after the RV maker said its board authorized a 7% dividend increase to 48 cents a share.

Silk Road Medical Inc. SILK, -0.71% shares dropped in the extended session Tuesday after the medical device company updated its forecast and said its chief executive was retiring. The company forecast

SUNNYVALE, Calif., Sept. 04, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that manage

SUNNYVALE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wi

Silk Road Medical, Inc. (NASDAQ:SILK ) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relations Erica Rogers - Chief Executive Officer Lucas Bu

Silk Road Medical (SILK) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to loss of $0.44 per share a year ago.

Silk Road Medical is a medical device maker specializing in cardiovascular therapies. The company reported revenue growth of 43% year over year in the first quarter.

Shares of Silk Road Medical Inc. SILK, -20.18% tanked 21.9% toward a more-than three-year low in premarket Tuesday, after an unfavorable government decision regarding Medicare coverage of carotid arte

SUNNYVALE, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report

Silk Road Medical continues to grow at a solid pace, while shares continue to be under pressure. Previously awarded a >20 times sales multiple, the valuation has come down to about 6 times sales.

This article is an investment recommendation based not on the critique of corporate productivity, competitive ability, or profit management measured by forecasts of EPS, but on communication skills. I

Silk Road Medical, Inc. (NASDAQ:SILK ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Marissa Bych - IR Erica Rogers - CEO Lucas Buchanan - CFO and COO Conference Call Par

Silk Road Medical (SILK) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to loss of $0.48 per share a year ago.